On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

GCH1

GTP cyclohydrolase 1

The GCH1 gene encodes the enzyme GTP cyclohydrolase 1, which is essential for synthesising tetrahydrobiopterin (BH4), a co-factor involved in neurotransmitter production and amino acid metabolism. GCH1 provides instructions for an enzyme critical in the production pathway of tetrahydrobiopterin (BH4).

Chromosome 14q22.2 AD/AR HGNC:4193 Tier C
GCH1 14q22.2 p arm q arm 14

GCH1 is located on the long (q) arm of chromosome 14, at band 14q22.2. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 14 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The GCH1 gene, or GTP cyclohydrolase 1, is fundamental for human health, as it directs the synthesis of the enzyme GTP cyclohydrolase 1. This enzyme is responsible for the initial step in producing tetrahydrobiopterin (BH4), a crucial molecule that acts as a co-factor in various biochemical reactions within the body. These reactions include the processing of amino acids and the creation of important neurotransmitters, which are vital for proper nerve cell communication and function.

Dysfunction of the GCH1 gene can disrupt these critical pathways, leading to a range of neurological symptoms. The gene's involvement in such fundamental biological processes highlights its significance in maintaining overall physiological balance.

What the gene does

The GCH1 gene provides the blueprint for the GTP cyclohydrolase 1 enzyme, which is pivotal in the body's metabolic processes. Specifically, this enzyme initiates the synthesis of tetrahydrobiopterin (BH4), a crucial co-factor required for several enzymatic reactions. BH4 is essential for the metabolism of certain amino acids, such as the conversion of phenylalanine to tyrosine, a process mediated by phenylalanine hydroxylase.

Beyond amino acid processing, BH4 is intimately involved in the synthesis of neurotransmitters, which are chemical messengers in the brain. It is required for the production of dopamine and serotonin, two neurotransmitters that regulate a wide array of functions including movement, mood, emotion, sleep, and appetite. The proper functioning of the GCH1-encoded enzyme is therefore vital for neurological health and overall physiological homeostasis.

Video: Genetics 101

Chromosome location

The GCH1 gene is situated on chromosome 14, specifically at position 14q22.2. This genomic location indicates its precise address within the human genome. The gene is translated into a protein composed of 250 amino acids.

Protein structure

The GCH1 protein, GTP cyclohydrolase 1, is composed of 250 amino acids. Its structural characteristics include a significant Disordered Region spanning amino acids 1 to 64. Disordered regions are often flexible and can play roles in protein-protein interactions and signalling.

Key variants

Variants within the GCH1 gene can lead to changes in the GTP cyclohydrolase 1 enzyme, potentially impairing its function. These genetic alterations can range from single base changes to larger deletions or insertions, and their impact varies depending on the specific variant and its location within the gene. Such variants are associated with a spectrum of conditions, often impacting neurological function due to the enzyme's critical role in neurotransmitter synthesis.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for GCH1.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.248dup
Duplication
p.Glu84fs Pathogenic/Likely pathogenic ★★☆☆ Dystonia 5
c.250G>T
single nucleotide variant
p.Glu84Ter Pathogenic ★★☆☆ GTP cyclohydrolase I deficiency
c.478A>T
single nucleotide variant
p.Lys160Ter Pathogenic/Likely pathogenic ★★☆☆ Dystonia 5
c.539A>G
single nucleotide variant
p.Gln180Arg Pathogenic/Likely pathogenic ★★☆☆ Dystonia 5
c.541+2T>C
single nucleotide variant
- Pathogenic ★★☆☆ GTP cyclohydrolase I deficiency
c.550C>T
single nucleotide variant
p.Arg184Cys Pathogenic/Likely pathogenic ★★☆☆ Dystonia 5
c.578_583del
Deletion
p.Ile193_Glu195delinsLys Pathogenic/Likely pathogenic ★★☆☆ GTP cyclohydrolase I deficiency
c.597del
Deletion
p.Ala200fs Pathogenic/Likely pathogenic ★★☆☆ GTP cyclohydrolase I deficiency
c.614T>A
single nucleotide variant
p.Val205Glu Pathogenic ★★☆☆ Dystonia 5
c.626+2dup
Duplication
- Pathogenic/Likely pathogenic ★★☆☆ GTP cyclohydrolase I deficiency

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Pathogenic variants in the GCH1 gene are associated with inherited conditions that primarily affect neurological function. One notable condition is GTP cyclohydrolase deficiency (Segawa disease), which can manifest with features such as dystonia and other movement disorders. The inheritance pattern for GCH1-related conditions can be either autosomal dominant or autosomal recessive, influencing the severity and presentation of symptoms.

Inheritance pattern

Conditions caused by pathogenic GCH1 variants typically follow autosomal dominant or autosomal recessive inheritance.

Carrier frequency by population How common is heterozygous GCH1 carrier status across ancestry groups?

UK clinical status

The GCH1 gene is recognised within the UK's NHS Genomic Medicine Service through its inclusion on several PanelApp panels. It is categorised as 'green' for conditions such as Dystonia, chorea or related movement disorder (adult and childhood onset), Early onset dystonia, Hereditary spastic paraplegia (adult and childhood onset), Intellectual disability, Likely inborn error of metabolism, Neurodegenerative disorders (adult onset), Neurotransmitter disorders, Parkinson Disease and Complex Parkinsonism, and Undiagnosed metabolic disorders. This indicates that there is strong evidence supporting a causal relationship between GCH1 variants and these conditions.

Frequently asked questions

What is the main function of the GCH1 gene?

The GCH1 gene provides instructions for the enzyme GTP cyclohydrolase 1, which is crucial for the first step in producing tetrahydrobiopterin (BH4). BH4 is a vital co-factor for processing amino acids and synthesising important neurotransmitters like dopamine and serotonin.

What health conditions are associated with GCH1 variants?

Variants in the GCH1 gene are primarily associated with GTP cyclohydrolase deficiency, also known as Segawa disease. This condition can lead to various neurological symptoms, including movement disorders such as dystonia.

How is GCH1-related GTP cyclohydrolase deficiency inherited?

GCH1-related GTP cyclohydrolase deficiency can be inherited in either an autosomal dominant or autosomal recessive manner. The specific inheritance pattern influences the presentation and severity of the condition.

References

  1. Longo N. Disorders of biopterin metabolism. Journal of inherited metabolic disease. 2009. PMID: 19234759
  2. Segawa M. Autosomal dominant GTP cyclohydrolase I (AD GCH 1) deficiency (Segawa disease, dystonia 5; DYT 5). Chang Gung medical journal. 2009. PMID: 19292934
  3. Trender-Gerhard I, Sweeney MG, Schwingenschuh P. Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. Journal of neurology, neurosurgery, and psychiatry. 2009. PMID: 19332422
  4. Clot F, Grabli D, Cazeneuve C. Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. Brain : a journal of neurology. 2009. PMID: 19491146
  5. Ohta E, Funayama M, Ichinose H. Novel mutations in the guanosine triphosphate cyclohydrolase 1 gene associated with DYT5 dystonia. Archives of neurology. 2006. PMID: 17101830
  6. Garavaglia B, Invernizzi F, Carbone ML. GTP-cyclohydrolase I gene mutations in patients with autosomal dominant and recessive GTP-CH1 deficiency: identification and functional characterization of four novel mutations. Journal of inherited metabolic disease. 2004. PMID: 15303002
  7. Müller U, Steinberger D, Topka H. Mutations of GCH1 in Dopa-responsive dystonia. Journal of neural transmission (Vienna, Austria : 1996). 2002. PMID: 11956954
  8. Shintaku H. Disorders of tetrahydrobiopterin metabolism and their treatment. Current drug metabolism. 2002. PMID: 12003346
  9. Blau N, Bonafé L, Thöny B. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Molecular genetics and metabolism. 2001. PMID: 11592814
  10. Thöny B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. The Biochemical journal. 2000. PMID: 10727395
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 4 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .